109 related articles for article (PubMed ID: 8428801)
1. Persistence of plasmin-mediated pro-urokinase activation on the surface of human monocytoid leukemia cells in vitro.
Tapiovaara H; Stephens RW; Vaheri A
Int J Cancer; 1993 Feb; 53(3):499-505. PubMed ID: 8428801
[TBL] [Abstract][Full Text] [Related]
2. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
[TBL] [Abstract][Full Text] [Related]
3. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
[TBL] [Abstract][Full Text] [Related]
4. Characterization of plasminogen activation by glycosylphosphatidylinositol-anchored urokinase.
Lee SW; Ellis V; Dichek DA
J Biol Chem; 1994 Jan; 269(4):2411-8. PubMed ID: 8300567
[TBL] [Abstract][Full Text] [Related]
5. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
Meissauer A; Kramer MD; Schirrmacher V; Brunner G
Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
[TBL] [Abstract][Full Text] [Related]
6. Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.
Berkenpas MB; Quigley JP
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7768-72. PubMed ID: 1652763
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.
Bizik J; Lizonová A; Stephens RW; Grófová M; Vaheri A
Cell Regul; 1990 Nov; 1(12):895-905. PubMed ID: 1712633
[TBL] [Abstract][Full Text] [Related]
8. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
Pöllänen J; Vaheri A; Tapiovaara H; Riley E; Bertram K; Woodrow G; Stephens RW
Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2230-4. PubMed ID: 2138329
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
Wolf BB; Vasudevan J; Henkin J; Gonias SL
J Biol Chem; 1993 Aug; 268(22):16327-31. PubMed ID: 8393859
[TBL] [Abstract][Full Text] [Related]
10. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
Lind SE; Smith CJ
Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
[TBL] [Abstract][Full Text] [Related]
12. A T-cell-related proteinase expressed by T-lymphoma cells activates their endogenous pro-urokinase.
Brunner G; Vettel U; Jobstmann S; Kramer MD; Schirrmacher V
Blood; 1992 Apr; 79(8):2099-106. PubMed ID: 1562736
[TBL] [Abstract][Full Text] [Related]
13. Alpha 2-macroglobulin restricts plasminogen activation to the surface of RC2A leukemia cells.
Stephens RW; Tapiovaara H; Reisberg T; Bizik J; Vaheri A
Cell Regul; 1991 Dec; 2(12):1057-65. PubMed ID: 1724917
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes.
Ellis V; Scully MF; Kakkar VV
J Biol Chem; 1989 Feb; 264(4):2185-8. PubMed ID: 2521625
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
Lijnen HR; De Cock F; Collen D
Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
[TBL] [Abstract][Full Text] [Related]
16. Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells.
Cohen RL; Xi XP; Crowley CW; Lucas BK; Levinson AD; Shuman MA
Blood; 1991 Jul; 78(2):479-87. PubMed ID: 1648983
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
[TBL] [Abstract][Full Text] [Related]
18. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
Odekon LE; Blasi F; Rifkin DB
J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the murine plasminogen/urokinase-type plasminogen-activator system.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1996 Nov; 241(3):840-8. PubMed ID: 8944773
[TBL] [Abstract][Full Text] [Related]
20. Binding and activation of plasminogen at the surface of human keratinocytes.
Reinartz J; Batrla R; Boukamp P; Fusenig N; Kramer MD
Exp Cell Res; 1993 Sep; 208(1):197-208. PubMed ID: 8359216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]